In diabetic mice, both MuRF1 and atrogin-1 gene expressions were significantly (p < 0.05, Figure 7C) increased as compared with the control mice, whereas BMP-7 treatment significantly (p < 0.05) reduced diabetes-induced MuRF1 and atrogin-1 gene expressions. The gene discussed is FBXO32; the disease is diabetes mellitus.